Brittany Cassin
Brittany Cassin is the CEO of DigiCARE Realized, a health technology company focused on modernizing care in complex brain disease through AI-powered decision intelligence applications. DigiCARE Realized is founded on technology developed at Indiana University.
As a former life science manufacturer executive, Brittany has 20+ years of healthcare commercialization experience, including the first-ever digital medicine system approved by the FDA in 2017. She has led health system partnerships and research collaborations in both serious mental illness and Alzheimer’s disease.
As a female, Hispanic founder, Brittany was named a 2022 finalist to the inaugural cohort of the National Institute on Aging (NIA) Start-Up Challenge. She also serves as a member of the CEOi Blood Based Bio-Marker Workgroup and is a collaborator to the Davos Alzheimer's Collaborative - System Preparedness Workgroup Flagship Program.
As a former life science manufacturer executive, Brittany has 20+ years of healthcare commercialization experience, including the first-ever digital medicine system approved by the FDA in 2017. She has led health system partnerships and research collaborations in both serious mental illness and Alzheimer’s disease.
As a female, Hispanic founder, Brittany was named a 2022 finalist to the inaugural cohort of the National Institute on Aging (NIA) Start-Up Challenge. She also serves as a member of the CEOi Blood Based Bio-Marker Workgroup and is a collaborator to the Davos Alzheimer's Collaborative - System Preparedness Workgroup Flagship Program.
